PCVX vs SYK
Vaxcyte, Inc. vs Stryker Corporation — AI-powered side-by-side comparison
PCVX
Vaxcyte, Inc.
70
Buy
VS
SYK
Stryker Corporation
70
Buy
| Metric | PCVX | SYK |
|---|
| AI Score |
70
|
70
|
| Price |
$58.08
|
$338.83
|
| P/E Ratio |
-7.60×
|
34.86×
|
| ROE |
-28.5%
|
14.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
0.0%
|
65.2%
|
| Debt / Equity |
0.04×
|
0.62×
|
| Dividend Yield |
0.0%
|
1.0%
|
| RSI (14) |
54.9
|
49.4
|
| Beta |
1.21
|
0.771
|
| Expected Upside |
+6.2%
|
+10.4%
|
AI Committee View
Current Innellis committee reasoning for PCVX versus SYK.
The committee scores are tied.
PCVX and SYK both score 70/100.
PCVX Committee View
67% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -37.6% -- cheap may mean cheap for a reason — Value
SYK Committee View
75% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- News sentiment is positive (+0.33 across 31 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical